Page last updated: 2024-08-21

pyrazines and fenofibrate

pyrazines has been researched along with fenofibrate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chojnowska-Jezierska, J; Jabłoński, S; Tkaczewski, W1
Bergemann, R; Brandt, A; Siegrist, W1
Cutfield, WS; Gluckman, PD; Hofman, PL; Lobie, PE; Vickers, MH1
Nie, J; Wang, F; Wang, H; Zhang, C1

Reviews

1 review(s) available for pyrazines and fenofibrate

ArticleYear
Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
    Discovery medicine, 2014, Volume: 18, Issue:98

    Topics: Animals; Blood-Retinal Barrier; Diabetic Retinopathy; Erythropoietin; Fenofibrate; Humans; Insulin-Like Growth Factor Binding Protein 3; Macular Edema; Protective Factors; Pyrazines; Sitagliptin Phosphate; Triazoles; Vascular Endothelial Growth Factor A

2014

Other Studies

3 other study(ies) available for pyrazines and fenofibrate

ArticleYear
[Clinical effectiveness of acipimox and fenofibrate in patients with hyperlipoproteinemia type II].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1993, Volume: 46, Issue:9-10

    Topics: Adult; Aged; Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Treatment Outcome

1993
Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).
    PharmacoEconomics, 1993, Volume: 3, Issue:2

    Topics: Bezafibrate; Cost-Benefit Analysis; Diabetes Complications; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Models, Econometric; Pyrazines; Treatment Outcome

1993
Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 291, Issue:6

    Topics: Animals; Birth Weight; Blood Pressure; Bone Development; Fatty Acids, Nonesterified; Female; Fenofibrate; Growth; Growth Hormone; Hematocrit; Hypolipidemic Agents; Insulin; Insulin-Like Growth Factor I; Liver; Male; Organ Size; Pregnancy; Pyrazines; Rats; Rats, Wistar; Tibia; Weight Gain

2006